Page last updated: 2024-08-24

imiquimod and Graft vs Host Disease

imiquimod has been researched along with Graft vs Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, CL; Chakraverty, R; Chorro, L; Conlan, T; Fallah-Arani, F; Flutter, B; Geissmann, F; Goold, H; Means, TK; Trouillet, C1
Bezak, KB; Durakovic, N; Fuchs, EJ; Luznik, L; Murphy, GF; Radojcic, V; Skarica, M1

Other Studies

2 other study(ies) available for imiquimod and Graft vs Host Disease

ArticleYear
Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin.
    Blood, 2011, Jun-30, Volume: 117, Issue:26

    Topics: Aminoquinolines; Animals; Cell Communication; Cells, Cultured; Chimera; Cytotoxicity, Immunologic; Epidermis; Gene Expression Regulation; Graft vs Host Disease; Granzymes; Imiquimod; Interferon-gamma; Langerhans Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; RNA, Messenger; T-Lymphocytes, Cytotoxic; TNF-Related Apoptosis-Inducing Ligand; Toll-Like Receptors; Tumor Necrosis Factor-alpha

2011
Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions.
    Journal of immunology (Baltimore, Md. : 1950), 2006, Oct-01, Volume: 177, Issue:7

    Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Bone Marrow Transplantation; Flow Cytometry; Graft vs Host Disease; Graft vs Host Reaction; Imiquimod; Langerhans Cells; Lymph Nodes; Major Histocompatibility Complex; Mice; Skin; T-Lymphocytes; Transplantation Chimera; Transplantation, Homologous; Transplants

2006